Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5638009 | Archives of Oral Biology | 2017 | 25 Pages |
Abstract
OTE shows antitumor activities in OSCC cells by inhibiting NF-κB, COX-2 and cyclin D1 and upregulation of p53 expression. It may be developed as a safe and promising alternative chemopreventive/chemotherapeutic agent for oral cancer.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Dentistry, Oral Surgery and Medicine
Authors
Ritu Arora, Vijaya Bharti, Poonam Gaur, Sadhna Aggarwal, Manasi Mittal, Satya N. Das,